Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe [1]
- Sandoz and Austrian government announce joint plans to drive long-term competitiveness of European production for key antibiotics in Europe
- Planned combined investment of more than EUR 150 million would include major innovative technology development and implementation for large-scale manufacture of active ingredients for leading penicillin products
- Kundl manufacturing site in Austria is hub of last vertically integrated antibiotics production chain in Europe; Sandoz is #1 global supplier of generic antibiotics
Global media release (English) [2]
German media release (Deutsch) [3]
LinkedIn article from Richard Saynor [4]
| Images: Sandoz site Kundl, Austria | ||
|---|---|---|
|
|
|
|
|
|
||
| Images: Management | ||
|---|---|---|
|
|
|
|
| Video message: Richard Saynor, CEO Sandoz (English) | ||
|---|---|---|
|
|
|
|
|
|
||
| Video message: Christian Pawlu, Head of Strategy, Portfolio and BD&L (German) | ||
|---|---|---|
|
|
|
|
|
|
||
| Videos and animation | ||
|---|---|---|
|
|
|
|
| B-Roll: Sandoz site Kundl, Austria | ||
|---|---|---|
|
|
||
Featured image:
Hero title:
Media Release
Accordion Type:
Collapsible